Holen Sie sich die Stockscreener-App
28.21
0.09%
0.0123
Schlusskurs vom Vortag:
$28.20
Offen:
$28.2
24-Stunden-Volumen:
228.79K
Relative Volume:
0.38
Marktkapitalisierung:
$1.32B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-61.33
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
+0.91%
1M Leistung:
-3.01%
6M Leistung:
-35.31%
1J Leistung:
-4.71%
1-Tages-Spanne:
$28.05
$28.91
1-Wochen-Bereich:
$26.84
$29.02
52-Wochen-Spanne:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
28.22 | 1.32B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
290.73 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.34 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.56 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.23 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.23 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
3 Healthcare Stocks We Approach with Caution - FinancialContent
What drives Omnicell Inc. stock priceRobust investment performance - jammulinksnews.com
Omnicell Inc. Stock Analysis and ForecastExponentially increasing returns - Autocar Professional
Is Omnicell Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
Robotic Pharmacy Automation System Market Set to Witness - openPR.com
What analysts say about Omnicell Inc. stockDouble-digit growth - jammulinksnews.com
Why Omnicell (OMCL) Stock Is Trading Up Today - TradingView
Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025 - GlobeNewswire Inc.
Wells Fargo raises Omnicell stock price target to $40 on reduced tariff impact - Investing.com Canada
Published on: 2025-07-18 21:34:02 - jammulinksnews.com
Benchmark reiterates Buy rating on Omnicell stock amid tariff uncertainties By Investing.com - Investing.com Canada
Adherence Packaging Market to Witness Massive Growth by CAGR - openPR.com
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Unexpected Trends Reshaping the Central Fill Pharmacy - openPR.com
Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 - BioSpace
Omnicell's Q2 Outlook: Autonomous Pharmacy Momentum and Undervalued Growth Catalysts - AInvest
Omnicell's Growth Uncertainty Amidst Market Challenges: A Hold Rating Analysis - AInvest
Omnicell to Release Second Quarter 2025 Financial Results on Jul - GuruFocus
Omnicell (OMCL) Faces Target Price Adjustment Amid Revenue Uncer - GuruFocus
A Hidden Reason Omnicell's Future Looks Bright - AOL.com
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Markets | American Financial Group, Inc. - FinancialContent
Medication Management System Market Set to Witness Significant - openPR.com
Omnicell stock maintains Buy rating at Craig-Hallum amid tariff adjustments - Investing.com Canada
3 Reasons to Sell OMCL and 1 Stock to Buy Instead - Yahoo Finance
Automated Medication Compounding System Market Generated - openPR.com
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Pharmacy Automation Devices Market Set to Witness Significant - openPR.com
Learn to Evaluate (OMCL) using the Charts - news.stocktradersdaily.com
Robotic Pharmacy Automation System Market Is Booming So Rapidly - openPR.com
Do Options Traders Know Something About Omnicell Stock We Don't? - The Globe and Mail
Omnicell Inc. to Pay $4.3 Million to Settle VA Overbilling Allegations - USA Herald
VA Contractor To Pay $4.3M To Resolve Overbilling Claims - Law360
Omnicell to pay $4.3M for overbilling VA in Spokane - NonStop Local KHQ
Unit Dose Drug Delivery Systems Market Booming with Hospital Safety Initiatives | Omnicell Inc., Baxter International - openPR.com
New Technology Developments in Robotic Dispensing System - openPR.com
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omnicell Inc-Aktie (OMCL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
1.01%
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):